FTC – Page 2 – Policy & Medicine

Policy and Medicine Compliance Update June 2023 Issue Features Update on Precision Lens Kickback Case, Novo Nordisk Legal Issues, Good RX FTC Case, and AI Compliance

AMGA Opposes FTC Non-Compete Clause Rule

GoodRx Fined in First Violation of the Health Breach Notification Rule

Groups Ask FTC to Investigate GPOs

Policy and Medicine Compliance Update October, 2022 Issue Covers HHS Self Disclosure and DOJ Enforcement Policies, Omnicare FCA Case, and Stem Cell Research

FTC Launches Inquiry into Pharmacy Benefit Manager Industry

FTC Seeks Comments on the Impact of Pharmacy Benefit Managers’ Practices

DOJ and FTC Aim to Increase Merger Enforcement

FTC Announces $40 Million Settlement with Vyera Pharmaceuticals

FTC Releases Report on Rebate Walls, Vows to Promote Competition in Industry